GGrantIndex
Sort

65,743 grants matching single cell sequencing

Project 1: Dynamic Genomic and Microenvironmental Models of Acquired Chemoresistance

$562,927
Andrea Hope Bild · Beckman Research Institute/City Of Hope · U54 · FY2018 · CA

Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity

$562,905
Deanna L Kroetz · University Of California, San Francisco · R01 · FY2022 · CA

Vaccina Virus DNA Topoisomerase

$562,903
Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2008 · GM

Neurotrophic Mechanisms in Cocaine and Opiate Action

$562,873
Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DA

Neurotrophic Mechanisms in Cocaine and Opiate Action

$562,873
Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DA

Neurotrophic Mechanisms in Cocaine and Opiate Action

$562,873
Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DA

Neurotrophic Mechanisms in Cocaine and Opiate Action

$562,873
Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · DA

Neurotrophic Mechanisms in Cocaine and Opiate Action

$562,873
Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DA

Define the role of chromosome 17q gain in neuroblastoma malignancy

$562,869
Miller Huang · Children'S Hospital Of Los Angeles · R01 · FY2025 · CA

Project 2: 3-D Molecular atlas of AD proteinopathy

$562,819
Vilas Menon · Columbia University Health Sciences · U19 · FY2023 · AG

Defining the role of an endothelial-adipocyte precursor axis in adipocyte hyperplasia

$562,800
Matthew S Rodeheffer · Yale University · R01 · FY2025 · DK

Defining the role of an endothelial-adipocyte precursor axis in adipocyte hyperplasia

$562,800
Matthew S Rodeheffer · Yale University · R01 · FY2023 · DK

Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis

$562,793
Alfred Ayala · Rhode Island Hospital · R35 · FY2023 · GM

Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis

$562,793
Alfred Ayala · Rhode Island Hospital · R35 · FY2022 · GM

Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis

$562,793
Alfred Ayala · Rhode Island Hospital · R35 · FY2025 · GM

Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis

$562,793
Alfred Ayala · Rhode Island Hospital · R35 · FY2024 · GM

The autophagy lysosomal pathway: regulation by progranulin and its role in neurodegenerative disease

$562,785
Steven M Finkbeiner · Northwestern University · P01 · FY2022 · AG

Neutralizing Antibodies to Hepatitis C

$562,782
Stanford University · R01 · FY2004 · HL

A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis

$562,781
Ute M Moll · State University New York Stony Brook · R01 · FY2024 · HL

Cells-to-sequence sample preparation for next-generation sequencing

$562,774
Truett C Boles · Sage Science, Inc. · R44 · FY2015 · HG

Defining mechanisms to promote antitumor immunity by modulating one-carbon metabolism

$562,761
Arlene H Sharpe · Harvard Medical School · R01 · FY2025 · CA

RNA editing in islet function and inflammation

$562,668
Alvin Carter Powers · Vanderbilt University Medical Center · R01 · FY2023 · DK

Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias

$562,661
Eric M Verdin · Buck Institute For Research On Aging · P01 · FY2025 · AG

Computational Approaches for RNA Structure and Function Determination

$562,649
Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

The landscape of NFκB transcription dynamics

$562,648
Elizabeth A. Komives · University Of California, San Diego · R01 · FY2025 · GM